(Q46468664)

22 December 2017

title

Two-hour postdose concentration: a reliable marker for cyclosporine exposure in adolescents with stable renal transplants (English)

1 reference

22 December 2017

1 reference

1 reference

John U

1

1 reference

22 December 2017

Ullrich S

series ordinal

2

1 reference

22 December 2017

Roskos M

series ordinal

3

1 reference

22 December 2017

Misselwitz J

series ordinal

4

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

22 December 2017

Transplantation Proceedings

published in

1 reference

22 December 2017

volume

37

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

1608-1611

1 reference

22 December 2017

Patient management by Neoral C(2) monitoring: an international consensus statement

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Clinical validation studies of Neoral C(2) monitoring: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Experience with cyclosporine: approaching the therapeutic window for C2 levels in maintenance kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Cyclosporin A monitoring by 2-h levels: preliminary target levels in stable pediatric kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Long-term predictive value of cyclosporine microemulsion C2 level for chronic renal allograft dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Neoral monitoring 2 hours post-dose and the pediatric transplant patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Longitudinal evaluation of the pharmacokinetics of cyclosporin microemulsion (Neoral) in pediatric renal transplant recipients and assessment of C2 level as a marker for absorption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Everolimus in pediatric de nova renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Single-dose pharmacokinetics and tolerability of everolimus in stable pediatric renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Recommendations for the implementation of Neoral C(2) monitoring in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Comparison of C0 and C2 cyclosporine monitoring in long-term renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

A strategy to calculate cyclosporin A area under the time-concentration curve in pediatric renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Cyclosporine absorption profiles in pediatric kidney and liver transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Mycophenolate mofetil-induced reversal of glomerular filtration loss in children with chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

Alterations of cyclosporin A metabolism induced by mycophenolate mofetil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.025

10.1016/J.TRANSPROCEED.2004.09.025

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017